Skip to main content
RSSS
NASDAQ Technology

$1M Enterprise Scite Deal With Fortune 500 Biopharma Is Largest in Company History

Tom Rudovsky · Reported by PR Newswire
More coverage: Software Stocks · Technology
Sentiment info
Positive
Importance info
7
Price
$1.81
Mkt Cap
$61.11M
52W Low
$1.77
52W High
$3.38
52W Position info
2.3% above low
Off High info
46% below high
Rel. Volume info
0.6× avg
Market data snapshot near publication time

RSSS is trading near its 52-week low of $1.77 (2.3% above the low).

Summary

Research Solutions signed a $1 million enterprise Scite agreement with a Fortune 500 biopharmaceutical company, its largest deal ever. The contract expands an existing Article Galaxy customer into a full Scite deployment across all research groups, including Scite API access and datasets so internal AI tools can search and cite peer-reviewed literature. Management said the deal followed a months-long evaluation spanning technical trials and procurement, legal, infosec and AI governance reviews, and CEO Roy Olivier called it evidence of broad pipeline demand rather than a one-off. The size matters for a company this small: $1 million is meaningful against a $2.8 million record FY2026 net income reported in the September 8-K and 10-K, and it lands with the stock near its 52-week low of $1.77. Watch whether management quantifies the enterprise pipeline on the next earnings update, and note the annual meeting set for November 16.

At the time of this announcement, RSSS was trading at $1.81 on NASDAQ in the Technology sector, with a market capitalization of approximately $61.1M. The 52-week trading range was $1.77 to $3.38. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: PR Newswire.


Price Chart

Share this article

Copied!

RSSS - Latest Insights

RSSS
May 15, 2026, 4:01 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $2.39
Real-time Price: $1.84 info
Change: -$0.5495 (-23%) info
Market Cap: $61.11M info
RSSS
May 14, 2026, 4:29 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $2.71
Real-time Price: $1.84 info
Change: -$0.8695 (-32%) info
Market Cap: $61.11M info
RSSS
Feb 13, 2026, 4:00 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $2.50
Real-time Price: $1.84 info
Change: -$0.6595 (-26%) info
Market Cap: $61.11M info
RSSS
Feb 12, 2026, 5:17 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $2.51
Real-time Price: $1.84 info
Change: -$0.6695 (-27%) info
Market Cap: $61.11M info